Version for the visually impaired:
Font size:
Language version:
Visit website TNRMC


Tatyana A. Dronova

Tatyana A. Dronova

Tatyana A. Dronova, Junior Researcher , Laboratory of Cancer Progression Biology, Cancer Research Institute, Tomsk NRMC, Post-graduate student at the Tomsk State University.



Brief Biography


2010-2016 – Student at the Biological Institute of Tomsk State University

2016 - present - Post-graduate student at the Tomsk State University

Work experience:

September 2019 - present - Junior Researcher, Laboratory of Cancer Progression Biology, Cancer Research Institute, Tomsk National Research Medical Center

2017 – present - Junior Researcher, Laboratory for Translational Cellular and Molecular Biomedicine, Tomsk State University

2016-2019 - Junior Researcher, Laboratory of Molecular Oncology and Immunology, Cancer Research Institute, Tomsk National Research Medical Center

Research Interests

Breast cancer, molecular - genetic markers, gene polymorphism, hormone therapy.

Achievements, awards, and grants


1. RSF No. 19-15-00151 “The role of monocyte programming in the development of pro- and anti-tumor phenotypes of tumor-associated macrophages and efficiency of chemotherapy in colorectal cancer”

2. RNF No. 14-15-00350 “Molecular mechanism of action of regulatory proteins of type 2 macrophages on tumor microenvironment and tumor progression”

3. RFBR No. 17-29-06037 "Genomic regulation of the breast cancer progression during chemotherapy"

4. RFBR No. 18-29-09046 “Ethnospecific mutations associated with breast cancer in the indigenous population of Siberia and Russian Far East”

Main Publications

1. Babyshkina N., Vtorushin S., Dronova T., Patalyak S., Slonimskaya E., Kzhyshkowska J.,· Cherdyntseva N., Choynzonov E./ Impact of estrogen receptor α on the tamoxifen response and prognosis in luminal‑A‑like and luminal‑B‑like breast cancer // Clinical and Experimental Medicine. – 2019. - Nov;19(4):547-556. doi: 10.1007/s10238-019-00583-6.

2. Dronova T.A., Babyshkina N.N., Zavyalova M.V., Patalyak S.V., Slonimskaya E.M., Cherdyntseva N.V., Kzhyshkowska J.G. Relation of EGFR/PI3K/AKT signaling components with tamoxifen efficacy in patients with estrogen-dependent breast cancer. Advances in Molecular Oncology. 2018;5(3):40-50. (In Russ.)

3. Babyshkina N.N., Vtorushin S.V., Dronova T.A., Krakhmal N.V., Zavyalova M.V., Tsyganov M.M., Patalyak S.V., Slonimskaya E.M., Cherdyntseva N.V. ROLE OF TRANSFORMING GROWTH FACTOR RECEPTOR B I TYPE (TGF-BRI) IN THE PROGRESSION OF THE LUMINAL BREAST CANCER SUBTYPE. Siberian journal of oncology. 2017;16(2):27-35. (In Russ.)

4. Nataliya Babyshkina, Marina Zavyalova, Natalia Tarabanovskaya, Tatyana Dronova, Nadejda Krakhmal, Elena Slonimskaya, Julia Kzhyshkowska, Evgeny Choynzonov, Nadejda Cherdyntseva. Predictive value of vascular endothelial growth factor receptor type 2 in triple-negative breast cancer patients treated with neoadjuvant chemotherapy. 2018 Jul;444(1-2):197-206. doi: 10.1007/s11010-017-3244-1

5. Babyshkina N, Vtorushin S, Zavyalova M, Patalyak S, Dronova T., Litviakov N, Slonimskaya E, Kzhyshkowska J, Cherdyntseva N, Choynzonov E. The distribution pattern of ERα expression, ESR1 genetic variation and expression of growth factor receptors: association with breast cancer prognosis in Russian patients treated with adjuvant tamoxifenClin Exp Med. 2017 Aug;17(3):383-393. doi: 10.1007/s10238-016-0428-z.

6. Babyshkina N.N., Zavyalova M.V., Bragina O.D., Dronova T.A., Slonimskaya E.M., Cherdyntseva N.V. Predictive Significance of Vascular Endothelial Growth Factor receptor VEGF-2 in triple-negative breast cancer patients. Siberian journal of oncology. 2016;15(5):9-17. (In Russ.)